SynthesisBiochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology
Educational Leadership for Sustainable Capacity Building Towards Enhancing Interdisciplinary Collaboration in Computer-Aided Drug Design and Network Pharmacology: A Systematic Review.
Synthesis in Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In the pharmaceutical sciences, particularly in network pharmacology and computer-aided drug design (CADD), successful multidisciplinary collaboration is crucial for sustainable capacity growth. This systematic study investigates how interdisciplinary research methods can be strengthened and creative technology integration may be fostered sustainably through educational leadership. For papers published between 2010 and 2024, a systematic literature search was carried out in the Scopus and Web of Science (WoS) databases. "Network pharmacology," "interdisciplinary collaboration," "pharmaceutical sciences," "computer-aided drug design," and "educational leadership" were among the search phrases used. Peer-reviewed papers, case studies, and reports discussing leadership in multidisciplinary pharmaceutical sciences research or instruction were among the eligible studies. Out of 558 identified records, 109 studies were included in accordance with PRISMA requirements (WoS = 476; Scopus = 82). With 10% of research focusing on CADD, 22% on educational leadership, and 68% on more general, multidisciplinary viewpoints, the results indicated a paradigm shift towards interdisciplinary collaboration. However, limitations were found because educational leadership was not included in CADD and network pharmacology frameworks in several studies. The main challenges to productive cooperation were identified as resource limitations, policy gaps, and communication difficulties. This analysis highlights how institutional frameworks, regulatory support, and adaptive leadership techniques are necessary to facilitate long-term knowledge sharing, innovation absorption, and better research outcomes in the pharmaceutical sciences. Therefore, enhancing educational leadership opens the door to long-term effects and sustained capacity building in multidisciplinary pharmaceutical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.